PAVM · PAVmed Inc.
$5.04
+0.00 (+0.00%)
At close · Aug 5
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying consolidated financial statements are issued.”View the 10-Q filed May 14, 2026
Market Cap
$35.93M
Shares
7.27M
PAVmed Inc. Earnings Call Transcripts
Every quarterly earnings call for PAVmed Inc. (PAVM) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼62%
$76,000
−$26.13M
'22 Q3
22-11-15
▲136%
$446,000
−$17.93M
'23 Q1
23-03-31
·
$166,000
−$14.54M
'23 Q2
23-06-30
▲940.8%
$791,000
−$17.67M
'23 Q3
23-11-15
·
$1.10M
−$14.04M
'23 Q4
23-12-31
▲124.2%
$1.00M
−$15.21M
'24 Q1
24-05-14
▲502.4%
$1.00M
−$10.83M
'24 Q2
24-08-13
▲26.4%
$1.00M
$64.40M
'24 Q3
24-11-14
▼100%
$
$1.43M
'24 Q4
25-03-25
▼99.2%
$8,000
$18.97M
'25 Q1
25-05-15
▼99.4%
$6,000
−$11.92M
'25 Q2
25-08-14
▼99.5%
$5,000
−$5.38M
'25 Q3
25-11-13
·
$52,000
−$1.26M
'25 Q4
26-03-30
LATEST
▲175%
$22,000
−$60,000
'26 Q1
26-05-15
Earnings call
FY26 · Q1
2026-05-15
PAVmed Inc. Q1 FY2026 Earnings Call
Confident tone
Capital structure restructuring
Medical device portfolio relaunch
Veris commercial rollout at OSU
Revenue
$22,000
▲ 175% YoY Diluted EPS
$-4.42
▼ 143.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-30
PAVmed Inc. Q4 FY2025 Earnings Call
Confident tone
Capital restructuring and balance sheet
MedTech portfolio relaunch and Duke imaging technology
Veris Health commercial launch with OSU
Revenue
$52,000*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-13
PAVmed Inc. Q3 FY2025 Earnings Call
Confident tone
Lucid Diagnostics / EsoGuard commercialization
Veris Cancer Care platform and OSU partnership
Implantable physiologic monitor / FDA submission
Revenue
$5,000
▼ 99.5% YoY Diluted EPS
$-8.70
▼ 120.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
PAVmed Inc. Q2 FY2025 Earnings Call
Revenue
$6,000
▼ 99.4% YoY Diluted EPS
$-22.20
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-15
PAVmed Inc. Q1 FY2025 Earnings Call
Confident tone
Lucid Diagnostics / e-cigars
Veris Health / digital health
Balance sheet / financing
Revenue
$8,000
▼ 99.2% YoY Diluted EPS
$10.20
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-25
PAVmed Inc. Q4 FY2024 Earnings Call
Revenue
$*
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-14
PAVmed Inc. Q3 FY2024 Earnings Call
Positive tone
Corporate restructuring and balance sheet
PMX incubator and PortIO device
Listing compliance risk
Revenue
$1.00M
▲ 26.4% YoY Diluted EPS
$43.20
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-13
PAVmed Inc. Q2 FY2024 Earnings Call
Positive tone
Veris Health pilot and financing
PMX Incubator / PortIO financing
Lucid Diagnostics / EsoGuard commercial progress
Revenue
$1.00M
▲ 502.4% YoY Diluted EPS
$-35.70
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
PAVmed Inc. Q1 FY2024 Earnings Call
Positive tone
Lucid and EsoGuard commercial progress
Veris Health pilot at Ohio State
PMX Incubator and PortIO
Revenue
$1.00M
▲ 124.2% YoY Diluted EPS
$-78.60
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
PAVmed Inc. Q4 FY2023 Earnings Call
Revenue
$1.10M*
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-15
PAVmed Inc. Q3 FY2023 Earnings Call
Revenue
$791,000
▲ 940.8% YoY Diluted EPS
$-72.00
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
PAVmed Inc. Q2 FY2023 Earnings Call
Revenue
$166,000
Diluted EPS
$-63.00
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
PAVmed Inc. Q1 FY2023 Earnings Call
Revenue
$446,000
▲ 136% YoY
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-15
PAVmed Inc. Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-15
PAVmed Inc. Q3 FY2022 Earnings Call
Revenue
$76,000
▼ 62% YoY
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-17
PAVmed Inc. Q2 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
PAVmed Inc. Q1 FY2022 Earnings Call
Revenue
$189,000
Gross margin
-95.2%
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-29
PAVmed Inc. Q4 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
PAVmed Inc. Q3 FY2021 Earnings Call
Revenue
$200,000
Gross margin
28.0%
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
PAVmed Inc. Q2 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-17
PAVmed Inc. Q1 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-22
PAVmed Inc. Q4 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-17
PAVmed Inc. Q3 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-18
PAVmed Inc. Q2 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-21
PAVmed Inc. Q1 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–25 of 25 earnings calls